Breakthrough CLL Treatments: The Latest Advances in Chronic Lymphocytic Leukemia
Patient advocate Andrew Schorr has been living with chronic lymphocytic leukemia for 26 years.
In this conversation, he talks with hematologist-oncologist Dr. Nitin Jain from the MD Anderson Cancer Center who specializes in patients with CLL and ALL.
They discuss the latest treatment and developments in CLL coming out of ASH, the American Society of Hematology, which took place December 2022 including the latest treatments and research in chronic lymphocytic leukemia.
Full story and transcript โ https://www.thepatientstory.co....m/medical-experts/cl
Join Our Community:
Website : https://www.thepatientstory.com/
Facebook: @ThePatientStory
Instagram: @ThePatientStory
Twitter: @patient_story
Contents of this Video:
00:00 - Intro
01:11 - How to choose the right drug for the right patient
05:55 - Ibrutinib
06:43 - Is the standard still "watch and wait" for CLL patients?
09:03 - Ibrutinib and venetoclax for the first-line treatment of CLL
10:34 - The importance of getting an infusion vs. oral medications?
12:29 - What is the advantage of a third generation BTK inhibitor?
14:03 - New data on Richter's transformation
18:32 - CAR T-cell therapy
#CLL #thepatientstory #cllsm #sll #chroniclymphocyticleukemia #leukemia #cancerstories #cancerpatient #cancersurvivor#bloodcancer #cancertreatments #bispecifics
-
Category
No comments found